EMA — authorised 20 September 2018
- Marketing authorisation holder: Pierre Fabre Medicament
- Status: approved
🇪🇺 Mektovi in European Union
EMA authorised Mektovi on 20 September 2018
Marketing authorisation
Mektovi in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Oncology approved in European Union
Frequently asked questions
Is Mektovi approved in European Union?
Yes. EMA authorised it on 20 September 2018.
Who is the marketing authorisation holder for Mektovi in European Union?
Pierre Fabre Medicament holds the EU marketing authorisation.